Blockade by burimamide of the effects of histamine and histamine analogs on cardiac contractility, phosphorylase activation and cyclic adenosine monophosphate.
D000262:Adenylyl Cyclases / Q000378:metabolism; D000818:Animals; D000242:Cyclic AMP / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D005021:Ethylamines / Q000494:pharmacology; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects*; D006493:Heparin / Q000494:pharmacology; D006632:Histamine / Q000494:pharmacology*; D006634:Histamine H1 Antagonists / Q000494:pharmacology*; D007093:Imidazoles / Q000494:pharmacology; D066298:In Vitro Techniques; D009206:Myocardium / Q000201:enzymology*; D009638:Norepinephrine / Q000494:pharmacology; D006005:Phosphorylases / Q000378:metabolism*; D011433:Propranolol / Q000494:pharmacology; D011720:Pyrazoles / Q000494:pharmacology; D013268:Stimulation, Chemical; D013806:Theophylline / Q000494:pharmacology; D013890:Thiourea / Q000494:pharmacology*; D013997:Time Factors; D014230:Triazoles / Q000494:pharmacology
D005021:Ethylamines; D006634:Histamine H1 Antagonists; D007093:Imidazoles; D011720:Pyrazoles; D014230:Triazoles; D006632:Histamine; D006493:Heparin; D011433:Propranolol; D013806:Theophylline; D000242:Cyclic AMP; D006005:Phosphorylases; D000262:Adenylyl Cyclases; D013890:Thiourea; D009638:Norepinephrine